Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

1.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
Nucleophilic Aromatic Substitution: Addition–Elimination (SNAr)01:30

Nucleophilic Aromatic Substitution: Addition–Elimination (SNAr)

4.6K
Nucleophilic substitution in aromatic compounds is feasible in substrates bearing strong electron-withdrawing substituents positioned ortho or para to the leaving group. The reaction proceeds via two steps: the addition of the nucleophile and the elimination of the leaving group.
The reaction begins with an attack of the nucleophile on the carbon that holds the leaving group. This results in the delocalization of the π electrons over the ring carbons. The resonance interaction between...
4.6K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

1.1K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.1K
Nucleophilic Aromatic Substitution of Aryldiazonium Salts: Aromatic SN101:14

Nucleophilic Aromatic Substitution of Aryldiazonium Salts: Aromatic SN1

2.6K
Treating arylamines with nitrous acid gives aryldiazonium salts that are effective substrates in nucleophilic aromatic substitution reactions. The diazonio group in these salts can be easily displaced by different nucleophiles, yielding a wide variety of substituted benzenes. The leaving group departs as nitrogen gas, and this easy elimination is the driving force for the substitution reaction.
In the Sandmeyer reaction, for example, the diazonio group is replaced by a chloro, bromo,...
2.6K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Quantification of Binding of Small Molecules to Native Kinases by Flow Cytometry Reveals Divergence from Biochemical Affinities.

Journal of the American Chemical Society·2026
Same author

Nitrosoarenes as Versatile Precursors for <sup>18</sup>F‑Fluorination.

ACS omega·2026
Same author

An Approach Toward Radioiodination and Radiopharmacological Evaluation of a Carborane-Containing Analog of Indomethacin.

Molecules (Basel, Switzerland)·2026
Same author

Next-Gen <sup>18</sup>F-Relay Reagent: Optimising [<sup>18</sup>F]Ethanesulfonyl Fluoride.

International journal of molecular sciences·2026
Same author

ERα-Independent Activity of Tamoxifen-Based Transition Metal Hybrids in Triple-Negative Breast Cancer Models In Vitro and In Vivo.

Molecules (Basel, Switzerland)·2026
Same author

Applications of Functional Nanomaterials in Biomedical Science.

Nanomaterials (Basel, Switzerland)·2026

相关实验视频

Updated: Jan 11, 2026

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
08:56

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

Published on: November 30, 2022

3.4K

在小说中,Ruthenacarborane-NSAID 结合剂.

Sonam Sonam1,2, Marija Mojić3, Vuk Gordić3

  • 1Institute of Bioanalytical Chemistry Centre for Biotechnology and Biomedicine (BBZ), Faculty of Chemistry, Leipzig University, Deutscher Platz 5, 04103 Leipzig, Germany.

Molecules (Basel, Switzerland)
|November 13, 2025
PubMed
概括

基于的抗癌药物候选药物,结合卡博兰和NSAIDs,没有表现出细胞毒性作用. 在这项研究中,氧化失活可能阻止了双重作用药物的开发.

关键词:
循环电压计 (CV) 是一种循环电压计.循环氧化原酶 (COX) 的使用.非类固醇抗炎药 (NSAIDs) 是一种非类固醇抗炎药.鲁特纳卡博拉尼 (ruthenacarborane) 是一种天然碳酸盐.

更多相关视频

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes
10:51

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Published on: April 10, 2015

12.6K
Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor
07:12

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor

Published on: October 26, 2017

8.1K

相关实验视频

Last Updated: Jan 11, 2026

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
08:56

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

Published on: November 30, 2022

3.4K
The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes
10:51

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Published on: April 10, 2015

12.6K
Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor
07:12

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor

Published on: October 26, 2017

8.1K

科学领域:

  • 有机金属化学 有机金属化学
  • 药品化学 药品化学 是一个
  • 癌症治疗治疗 癌症治疗

背景情况:

  • 基于的化疗具有显著的副作用,推动了对替代品的研究.
  • 有机金属化合物为癌症治疗提供独特的生化特性.
  • 与NSAIDs结合的鲁特纳卡博兰是一种潜在的双重作用治疗策略.

研究的目的:

  • 为了合成和表征新型的鲁特纳碳--6-p-烯) -NSAID结合物.
  • 评估这些结合物作为双作用抗癌剂的潜力.
  • 研究它们生物活动背后的机制.

主要方法:

  • 使用甲基烯和乙烯链接剂合成鲁丁纳碳 - - - - - - - - - - - - - - - - 合物.
  • 通过多核NMR光谱 (1H,11B,13C) 进行表征.
  • 对抗癌细胞系的COX抑制和细胞毒性的评估;用于氧化失活性的评估,循环电量计 (CV).

主要成果:

  • 成功合成和表征了四种ruthenacarborane-NSAID结合物.
  • 结合剂表现出较低的COX抑制.
  • 针对测试的癌症细胞系,没有观察到显著的细胞毒性活性,可能是由于氧化失活.

结论:

  • 合成的鲁丁纳卡博-NSAID结合物没有抗癌活性.
  • 氧化失活似乎是这一类化合物的限制因素.
  • 需要进一步的研究来克服这些限制,以开发有效的以为基础的抗癌药物.